Children's Hospital of Fudan University
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China20 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Spinal Muscular Atrophies of Childhood, Spinal Muscular Atrophy Type I, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Recruiting | Phase 1 / Phase 2 | 2026-08-26 | NCT07554924 | |
| Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Not yet recruiting | Phase 3 | 2026-08-14 | NCT07765914 | |
| Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Phase 4 | 2026-07-22 | NCT07719140 | |
| A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS]) | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 3 | 2026-07-20 | NCT07208058 | |
| The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Imprinting Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Prader-Willi syndrome, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-07-06 | NCT05791604 | |
| Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Enrolling by invitation | Not stated | 2026-06-02 | NCT06101940 | |
| A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major | β-thalassemia Major | Not yet recruiting | Phase 2 | 2026-03-24 | NCT07489196 | |
| Intervention for Children With Type 1 Diabetes Targeting Gut Microbes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Not applicable | 2026-03-17 | NCT06198725 | |
| Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes | Lipodystrophy Acquired; Type1diabetes | Active, not recruiting | Not applicable | 2026-03-17 | NCT03936829 | |
| Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, inborn error of immunity, metabolic disease, type 1 diabetes mellitus | Recruiting | Not applicable | 2026-03-17 | NCT03835312 | |
| Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm | Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Severe Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-03-16 | NCT04850456 | |
| ECMO Treatment of Children in China in the Past 10 Years | Child, Only; Extracorporeal Membrane Oxygenation | Recruiting | Not stated | 2026-03-16 | NCT04709432 | |
| Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children | Carbapenem-Resistant Enterobacteriaceae Infection | Recruiting | Not stated | 2026-03-16 | NCT04535661 | |
| Application of Early Bundle Management of Mechanical Ventilation to Prevent Ventilator Dependence in Children | Prolonged Mechanical Ventilation | Recruiting | Not applicable | 2026-02-17 | NCT06125210 | |
| Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections | Infections | Recruiting | Not stated | 2026-02-17 | NCT04923828 | |
| Newly-diagnosed Pediatric Ph-positive B-ALL Protocol | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2025-09-03 | NCT07152041 | |
| Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2025-08-26 | NCT06882057 | |
| Newly-diagnosed Pediatric T-cell ALL Protocol | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 / Phase 3 | 2025-08-26 | NCT06855810 | |
| Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature | Short Stature Children Born Small for Gestational Age (SGA) | Active, not recruiting | Phase 2 | 2025-05-25 | NCT02375620 | |
| Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, hereditary disease, pregnancy disorder, pregnancy disorder with abortive outcome | Recruiting | Not stated | 2025-02-20 | NCT04905537 |